EISAI R&D MANAGEMENT CO., LTD. — TTAB Proceedings
EISAI R&D MANAGEMENT CO., LTD. is a party to 12 TTAB proceedings.
Proceedings
- Proceeding 98094452 — Extensions of Time to Oppose, Terminated (filed 2024-07-22) against Blue Cross and Blue Shield of South Carolina, Inc. as defendant
- Proceeding 86291243 — Extensions of Time to Oppose, Terminated (filed 2014-11-07) against Ortega,Victor as plaintiff
- Proceeding 91195603 — Oppositions, Terminated (filed 2010-07-08) against Merck KGAA as defendant
- Proceeding 91180850 — Oppositions, Terminated (filed 2007-11-20) against Apogenix GmbH as plaintiff
- Proceeding 77886061 — Extensions of Time to Oppose, Terminated (filed 2010-05-27) against MERCK KGAA as defendant
- Proceeding 77300442 — Extensions of Time to Oppose, Terminated (filed 2008-04-24) against Aciex, Inc. as plaintiff
- Proceeding 77097283 — Extensions of Time to Oppose, Terminated (filed 2007-12-28) against Sanofi-Aventis U.S. LLC as defendant
- Proceeding 91177389 — Oppositions, Terminated (filed 2007-05-18) against Hoffmann-La Roche Inc. as defendant
- Proceeding 77060169 — Extensions of Time to Oppose, Terminated (filed 2007-08-14) against Apogenix GmbH as plaintiff
- Proceeding 77067840 — Extensions of Time to Oppose, Terminated (filed 2007-07-02) against Glaxo Group Limited as defendant
- Proceeding 78859117 — Extensions of Time to Oppose, Terminated (filed 2006-11-29) against Hoffmann-La Roche Inc. as defendant
- Proceeding 78859127 — Extensions of Time to Oppose, Terminated (filed 2006-12-19) against Merck KGaA as defendant
Marks in These TTAB Matters
- LEQEMBI COMPANION — proceeding 98094452 (Defendant)
- Trademark 77886061 — proceeding 91195603 (Defendant)
- Trademark 77886061 — proceeding 77886061 (Defendant)
- HALAVEN — proceeding 77097283 (Defendant)
- ARICEPT — proceeding 91180850 (Plaintiff)
- ARICEPT ODT — proceeding 91180850 (Plaintiff)
- HALISTA — proceeding 77067840 (Defendant)
- VALZID — proceeding 91177389 (Defendant)
- CIDION — proceeding 78859127 (Defendant)
- VALZID — proceeding 78859117 (Defendant)
Recent Live Filings
- EVOLPATH — Registered, filed 2024-11-06
- THRUBARRIER — Registered, filed 2024-11-06
- BRAINWING — Registered, filed 2024-11-06
- EISAI — Registered, filed 2023-11-06
- EISAI — Pending, filed 2023-11-06
- FRAPUMA — Registered, filed 2023-08-30
- LEQEMBI COMPANION — Pending, filed 2023-07-20
- Trademark 98082551 — Registered, filed 2023-07-12
- NEURII — Registered, filed 2023-07-12
- Trademark 98080550 — Pending, filed 2023-07-11
- NEURII — Registered, filed 2023-06-08
- LEQEMBI CLICKSURE — Pending, filed 2023-03-06
- LEQEMBI CLIQSURE — Pending, filed 2023-03-06
- LEQEMBI IQLIK — Pending, filed 2023-03-06
- Trademark 97777281 — Registered, filed 2023-02-01
Common TTAB Counterparties
- MERCK KGAA — 3 proceedings
- Apogenix GmbH — 2 proceedings
- Hoffmann-La Roche Inc. — 2 proceedings
- Aciex, Inc. — 1 proceedings
- Blue Cross and Blue Shield of South Carolina, Inc. — 1 proceedings
- Glaxo Group Limited — 1 proceedings
- Ortega,Victor — 1 proceedings
- Sanofi-Aventis U.S. LLC — 1 proceedings
Recent TTAB Timeline
- 2024-10-30: 98094452 — EXTENSION OF TIME GRANTED involving Blue Cross and Blue Shield of South Carolina, Inc.
- 2024-10-30: 98094452 — FINAL 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Blue Cross and Blue Shield of South Carolina, Inc.
- 2024-07-22: 98094452 — EXTENSION OF TIME GRANTED involving Blue Cross and Blue Shield of South Carolina, Inc.
- 2024-07-22: 98094452 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Blue Cross and Blue Shield of South Carolina, Inc.
- 2015-02-23: 86291243 — EXTENSION OF TIME GRANTED involving Ortega,Victor
- 2015-02-23: 86291243 — INCOMING - EXT TIME TO OPPOSE FILED involving Ortega,Victor
- 2014-11-07: 86291243 — EXTENSION OF TIME GRANTED involving Ortega,Victor
- 2014-11-07: 86291243 — INCOMING - EXT TIME TO OPPOSE FILED involving Ortega,Victor
- 2011-06-28: 91195603 — TERMINATED involving Merck KGAA
- 2011-06-28: 91195603 — BD'S DECISION: DISMISSED W/O PREJUDICE involving Merck KGAA
- 2011-06-08: 91195603 — WITHDRAWAL OF OPPOSITION involving Merck KGAA
- 2011-03-16: 91195603 — SUBMITTED ON BRIEF involving Merck KGAA
- 2011-03-10: 91195603 — ANSWER involving Merck KGAA
- 2011-01-07: 91180850 — TERMINATED involving Apogenix GmbH
- 2011-01-07: 91180850 — BD'S DECISION: DISMISSED W/ PREJUDICE involving Apogenix GmbH
- 2010-12-23: 91180850 — WITHDRAWAL OF OPPOSITION involving Apogenix GmbH
- 2010-12-13: 91195603 — SUSPENDED involving Merck KGAA
- 2010-12-13: 91195603 — STIP TO SUSPEND PEND SETTLEMENT NEGOTNS involving Merck KGAA
- 2010-12-06: 91180850 — RESPONSE DUE 30 DAYS (DUE DATE) involving Apogenix GmbH
- 2010-11-22: 91180850 — MOT TO AMEND APPLICATION involving Apogenix GmbH
- 2010-11-09: 91180850 — SUSPENDED involving Apogenix GmbH
- 2010-10-26: 91180850 — P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Apogenix GmbH
- 2010-10-14: 91195603 — EXTENSION OF TIME GRANTED involving Merck KGAA
- 2010-10-14: 91195603 — STIPULATION FOR AN EXTENSION OF TIME involving Merck KGAA
- 2010-09-30: 91180850 — SUSPENDED involving Apogenix GmbH
- 2010-09-24: 91180850 — P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Apogenix GmbH
- 2010-08-27: 91180850 — P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Apogenix GmbH
- 2010-08-11: 91195603 — EXTENSION OF TIME GRANTED involving Merck KGAA
- 2010-08-11: 91195603 — STIPULATION FOR AN EXTENSION OF TIME involving Merck KGAA
- 2010-08-05: 91180850 — SUSP PEND DISP OF OUTSTNDNG MOT involving Apogenix GmbH